Interpreting differences in quality of life: The FACT-H&N in laryngeal cancer patients

被引:68
作者
Ringash, J
Bezjak, A
O'Sullivan, B
Redelmeier, DA
机构
[1] Univ Hlth Network, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 1M9, Canada
[2] Sunnybrook & Womens Hosp, Toronto, ON, Canada
[3] Inst Clin Evaluat Sci, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
关键词
laryngeal neoplasms; minimal important difference; quality of life; questionnaires;
D O I
10.1023/B:QURE.0000021703.47079.46
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Quality of life (QOL) scores can be difficult to interpret, because small statistically significant differences can be clinically unimportant. Our goal was to estimate the magnitude of difference in QOL that is noticeable to patients. Methods: Laryngeal cancer patients (n = 98, male = 83%, mean age = 65) completed a QOL questionnaire, FACT-H&N. Paired participants rated their own QOL as compared to each other. We estimated the smallest difference in QOL score that was associated with a noticeable difference in patients' subjective ratings. Results: Differences in FACT-H&N score were somewhat correlated with patients' ratings of their well-being relative to other patients (r = 0.195, p < 0.0001). The FACT-H&N score had to differ by 6.22 for patients to rate themselves as `a little bit better' relative to other patients (95% CI: 1.42-11.02), and by 12.40 for patients to rate themselves as `a little bit worse' relative to others (95% CI: 5.09-19.71). Results were consistent regardless of patient age, gender or laryngeal subsite but were imperfect predictors of individual judgements. Conclusion: The minimal important difference for the FACT-H&N score is about 6-12 units, but laryngeal cancer survivors may be more sensitive to gains than losses.
引用
收藏
页码:725 / 733
页数:9
相关论文
共 31 条
[1]  
Brant R, 1999, STAT MED, V18, P2593, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2593::AID-SIM392>3.0.CO
[2]  
2-T
[3]   Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening [J].
Cella, D ;
Hahn, EA ;
Dineen, K .
QUALITY OF LIFE RESEARCH, 2002, 11 (03) :207-221
[4]  
Cella D, 1997, MANUAL FUNCTIONAL AS
[5]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[6]  
DAntonio LL, 1996, ARCH OTOLARYNGOL, V122, P482
[7]   Advanced laryngeal cancer T3-T4 in Sweden: A retrospective study 1986-1990. Survival and locoregional control related to treatment [J].
Finizia, C ;
Geterud, A ;
Holmberg, E ;
Lindstrom, J ;
Lundgren, J ;
Klintenberg, C ;
Kuylenstierna, R ;
Rylander, R ;
Biorklund, A ;
Rydell, R ;
Andreason, L ;
Mercke, C .
ACTA OTO-LARYNGOLOGICA, 1996, 116 (06) :906-912
[8]  
FORESTIERE AA, 2001, J CLIN ONCOL, V20, pA2
[9]  
Guyatt G.H., 1991, CONTROL CLIN TRIALS, V12, p266S, DOI [10.1016/s0197-2456(05)80030-3, DOI 10.1016/S0197-2456(05)80030-3]
[10]   MEASUREMENT OF HEALTH-STATUS - ASCERTAINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE [J].
JAESCHKE, R ;
SINGER, J ;
GUYATT, GH .
CONTROLLED CLINICAL TRIALS, 1989, 10 (04) :407-415